Side-by-side financials for AUTL and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AUTL | BNTX |
|---|---|---|
| Market cap | - | $22.18 B |
| US-listed rank | - | #582 |
| Revenue (latest FY) | $75.39M | - |
| Net income (latest FY) | -$287.53M | - |
| Net margin | -381.4% | - |
| SEC filings | 305 | 548 |
Full pages: Autolus Therapeutics plc and BioNTech SE, or browse the full rankings.